$5.05
-0.0160 (-0.316%)
At Close: Jul 31, 2026
Elekta AB (publ) (EKTAF) Q1 2024 Earnings Call Transcript
04:23pm, Thursday, 24'th Aug 2023
Elekta AB (publ) (OTCPK:EKTAF) Q1 2024 Earnings Conference Call August 24, 2023 4:00 AM ET Company Participants Cecilia Ketels - Head, IR Gustaf Salford - President & CEO Tobias Hagglov - CFO Conferen
Elekta AB (publ) (EKTAF) Q3 2023 Earnings Call Transcript
10:54am, Friday, 24'th Feb 2023
Elekta AB (publ) (OTCPK:EKTAF) Q3 2023 Earnings Conference Call February 24, 2023 4:00 AM ET Company Participants Cecilia Ketels - Head of Investor Relations Gustaf Salford - President & Chief Executi
Elekta AB (publ) (EKTAF) Q2 2023 Earnings Call Transcript
08:50am, Thursday, 24'th Nov 2022
Elekta AB (publ) (OTCPK:EKTAF) Q2 2023 Results Conference Call November 24, 2022 12:00 PM ET Company Participants Cecilia Ketels - Head of IR Gustaf Salford - President & CEO Tobias Hagglov - CFO Conf
Elekta AB (publ) (EKTAF) Q1 2023 Earnings Call Transcript
03:55pm, Thursday, 25'th Aug 2022
Elekta AB (publ) (OTCPK:EKTAF) Q1 2023 Earnings Conference Call August 25, 2022 4:00 AM ET Company Participants Cecilia Ketels - Head of IR Gustaf Salford - President & CEO Tobias Hagglov - CFO Confer
Elekta AB (publ)'s (EKTAF) CEO Gustaf Salford on Q4 2022 Results - Earnings Call Transcript
11:48am, Wednesday, 25'th May 2022
Elekta AB (publ) (OTCPK:EKTAF) Q4 2022 Earnings Conference Call May 25, 2022 4:00 AM ET Company Participants Cecilia Ketels - Head of Investor Relations Gustaf Salford - President and Chief Executive
Elekta AB (publ) 2022 Q3 - Results - Earnings Call Presentation
10:53pm, Monday, 28'th Feb 2022 Seeking AlphaElekta AB (publ) (EKTAF) CEO Gustaf Salford on Q3 2022 Results - Earnings Call Transcript
02:35pm, Saturday, 26'th Feb 2022 Seeking AlphaElekta AB (publ) (EKTAF) CEO Gustaf Salford on Q3 2022 Results - Earnings Call Transcript
09:35am, Saturday, 26'th Feb 2022
Elekta AB (publ) Q3 2022 Earnings Conference Call February 24, 2022 4:00 AM ET
Radiotherapy Market Size Worth $10,170.80 Million, Globally, by 2028 at 5.9% CAGR - Exclusive Report by The Insight Partners
06:43pm, Thursday, 16'th Dec 2021 Benzinga
New York, Dec. 17, 2021 (GLOBE NEWSWIRE) -- According to the new market research report " Radiotherapy Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (External-Beam Radiation Therapy, Internal Radiation Therapy, and Systemic Radiotherapy/Radiopharmaceuticals), Product (External Beam Radiotherapy Products, Internal Radiotherapy Products, Radiotherapy Software, and Others), Application (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Lymphoma, Liver Cancer, Thyroid Cancer, Brain Cancer, Cervical Cancer, Spine Cancer, and Others), and End User (Hospitals, Radiation Therapy Centers, and Specialty Clinics), and Geography", published by The Insight Partners , the global radiotherapy market was valued at US$ 6,474.78 million in 2020 and it is projected to reach US$ 10,170.80 million by 2028; it is expected to grow at a CAGR of 5.9% from 2021 to 2028. Get Exclusive Sample Pages of Radiotherapy Market Size - COVID-19 Impact and Global Analysis with Strategic Insights: https://www.theinsightpartners.com/sample/TIPMD00002668/ Radiotherapy Market: Competition Landscape and Key Developments Siemens Healthineers AG, Accuray Incorporated, Sumitomo Heavy Industries, Ltd., Elekta AB, Hitachi, Ltd., Koninklijke Philips N.V., Brainlab AG, PROTOM INTERNATIONAL, Varian Medical Systems, Inc., Maastro, and Mevion Medical Systems are among the key companies operating in the radiotherapy market.
Nasdaq Stockholm AB: Listing of bond loan issued by Elekta AB on STO Sustainable Bonds (477/21)
04:17pm, Monday, 13'th Dec 2021 FinanzNachrichten
Nasdaq Stockholm decides to officially list 1 bond loan issued by Elekta AB with effect from 2021-12-14. Last day of trading is set to 2026-12-03, 2028-12-01. The instrument will be listed on STO S…
Elekta AB (publ) (OTCMKTS:EKTAY) Sees Large Decrease in Short Interest
04:04pm, Saturday, 04'th Dec 2021 Dakota Financial News
Elekta AB (publ) (OTCMKTS:EKTAY) was the recipient of a significant drop in short interest in November. As of November 15th, there was short interest totalling 12,800 shares, a drop of 30.1% from the October 31st total of 18,300 shares. Based on an average daily trading volume, of 14,400 shares, the short-interest ratio is presently 0.9 []
Elekta AB (publ) (EKTAF) CEO Gustaf Salford on Q2 2022 Results - Earnings Call Transcript
02:39pm, Thursday, 25'th Nov 2021
Elekta AB (publ) (EKTAF) CEO Gustaf Salford on Q2 2022 Results - Earnings Call Transcript
Gamma Knife Market Enhanced Growth with Major Companies: Elekta AB, Varian Medical Systems, Inc., Accuray Incorporated, GENERAL ELECTRIC COMPANY
05:43am, Friday, 19'th Nov 2021 OpenPR
Gamma Knife Market report considers the latest upgrades while assessing the development of leading market players. This global market report is comprehensive and opens a door of worldwide market for the products. The report gives helpful insights which assist while
Elekta AB (publ) (EKTAF) CEO Gustaf Salford on Q1 2022 Results - Earnings Call Transcript
08:13am, Wednesday, 25'th Aug 2021
Elekta AB (publ) (EKTAF) CEO Gustaf Salford on Q1 2022 Results - Earnings Call Transcript
Sign In
Buy EKTAY